Explore another treatment option for psoriatic arthritis or ulcerative colitis.
APPROVED in pediatric patients with moderately to severely active ulcerative colitis who weigh at least 15 kg
FOR HEALTHCARE PROVIDERS
SIMPONI®: An Injection Experience to Consider for Your Patients
Select an indication below for more information:
RA
Adults With Moderate to Severe Rheumatoid Arthritis*
PsA
Adults With Active
Psoriatic Arthritis†
AS
Adults With Active
Ankylosing Spondylitis
UC
Adults With
Moderately to Severely Active
Ulcerative Colitis
pUC
Pediatric Patients Weighing at Least 15 kg
With Moderately to Severely Active
Pediatric Ulcerative Colitis
*In combination with methotrexate.
†Alone or in combination with methotrexate.